Androgen Receptor CAG Repeat Length is Not Associated with the Risk of Incident Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial

This study examined whether androgen receptor (AR) CAG repeat length was associated with the risk of incident benign prostatic hyperplasia (BPH), in a nested case-control study of 416 BPH cases and 527 controls drawn from Prostate Cancer Prevention Trial placebo-arm participants who were free of BPH...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kristal, Alan R, Price, Douglas K., Till, Cathee, Schenk, Jeannette M, Neuhouser, Marian L., Ockers, Sandy, Lin, Daniel W., Thompson, Ian M., Figg, William D.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904425/
https://ncbi.nlm.nih.gov/pubmed/19938041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21092
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items